Patient #2 presented with a p.S241fs deletion in both the HER2‐positive DCIS and the HER2‐positive invasive component, whereas the HER2‐negative DCIS component harboured a p.R273C missense variant. The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.